354 related articles for article (PubMed ID: 26245871)
41. ent-Sauchinone as Potential Anticancer Agent Inhibiting Migration and Invasion of Human Liver Cancer Cells via Suppressing the STAT3 Signaling Pathway.
Gong QZ; Xiao D; Feng F; Wen XD; Qu W
Chem Biodivers; 2018 Apr; 15(4):e1800024. PubMed ID: 29495104
[TBL] [Abstract][Full Text] [Related]
42. In vitro malignant conversion of low-grade rat urinary bladder carcinoma cells by exposure to N-methyl-N-nitrosourea.
Azuma M; Momose H; Oyasu R
Cancer Res; 1990 Nov; 50(21):7062-7. PubMed ID: 2208174
[TBL] [Abstract][Full Text] [Related]
43. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
Wirger A; Perabo FG; Burgemeister S; Haase L; Schmidt DH; Doehn C; Mueller SC; Jocham D
Anticancer Res; 2005; 25(6B):4341-7. PubMed ID: 16309238
[TBL] [Abstract][Full Text] [Related]
44. Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model.
Steinberg GD; Brendler CB; Ichikawa T; Squire RA; Isaacs JT
Cancer Res; 1990 Oct; 50(20):6668-74. PubMed ID: 2208131
[TBL] [Abstract][Full Text] [Related]
45. Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model.
Zhang J; Ahn KS; Kim C; Shanmugam MK; Siveen KS; Arfuso F; Samym RP; Deivasigamanim A; Lim LH; Wang L; Goh BC; Kumar AP; Hui KM; Sethi G
Antioxid Redox Signal; 2016 Apr; 24(11):575-89. PubMed ID: 26649526
[TBL] [Abstract][Full Text] [Related]
46. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
47. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
Zhou Y; Wu D; Tao J; Qu P; Zhou Z; Hou J
Scand J Urol; 2013 Oct; 47(5):423-32. PubMed ID: 23206218
[TBL] [Abstract][Full Text] [Related]
49. Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer.
Lin SY; Chang HH; Lai YH; Lin CH; Chen MH; Chang GC; Tsai MF; Chen JJ
PLoS One; 2015; 10(5):e0123305. PubMed ID: 25955608
[TBL] [Abstract][Full Text] [Related]
50. A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model.
Xiao Z; Mak A; Koch K; Moore RB
BJU Int; 2013 Jul; 112(2):E201-10. PubMed ID: 23356235
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer.
Su Q; Tao T; Tang L; Deng J; Darko KO; Zhou S; Peng M; He S; Zeng Q; Chen AF; Yang X
J Cell Mol Med; 2018 May; 22(5):2774-2790. PubMed ID: 29512924
[TBL] [Abstract][Full Text] [Related]
52. Kahweol blocks STAT3 phosphorylation and induces apoptosis in human lung adenocarcinoma A549 cells.
Kim HG; Hwang YP; Jeong HG
Toxicol Lett; 2009 May; 187(1):28-34. PubMed ID: 19429240
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
54. Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathway.
Joung YH; Na YM; Yoo YB; Darvin P; Sp N; Kang DY; Kim SY; Kim HS; Choi YH; Lee HK; Park KD; Cho BW; Kim HS; Park JH; Yang YM
Int J Oncol; 2014 Mar; 44(3):883-95. PubMed ID: 24402583
[TBL] [Abstract][Full Text] [Related]
55. Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3.
Yang J; Ren Y; Lou ZG; Wan X; Weng GB; Cen D
Acta Pharm; 2018 Jun; 68(2):211-222. PubMed ID: 29702481
[TBL] [Abstract][Full Text] [Related]
56. STAT3 signaling pathway in drug-resistant bladder cancer cell line.
Lei T; Zhou S; Meng Q; Zhang M
J Biol Regul Homeost Agents; 2019; 33(5):1347-1357. PubMed ID: 31912690
[TBL] [Abstract][Full Text] [Related]
57. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions.
Bi YH; Han WQ; Li RF; Wang YJ; Du ZS; Wang XJ; Jiang Y
World J Gastroenterol; 2019 Apr; 25(16):1936-1949. PubMed ID: 31086462
[TBL] [Abstract][Full Text] [Related]
58. MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway.
Sun D; Sawada A; Nakashima M; Kobayashi T; Ogawa O; Matsui Y
Urol Oncol; 2015 Mar; 33(3):111.e17-26. PubMed ID: 25499922
[TBL] [Abstract][Full Text] [Related]
59. Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer.
Arantes-Rodrigues R; Pinto-Leite R; Ferreira R; Neuparth MJ; Pires MJ; Gaivão I; Palmeira C; Santos L; Colaço A; Oliveira P
Biomed Pharmacother; 2013 May; 67(4):277-84. PubMed ID: 23582791
[TBL] [Abstract][Full Text] [Related]
60. Fluoxetine inactivates STAT3/NF-κB signaling and promotes sensitivity to cisplatin in bladder cancer.
Yang CJ; Tan ZL; Yang JD; Hsu FT; Chiang CH
Biomed Pharmacother; 2023 Aug; 164():114962. PubMed ID: 37276643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
